As an illustrative example, we performed single-cell RNA sequencing on pre-sorted CD34+ cells obtained at diagnosis and at post-transplant relapse of an AML patient with IDH2, DNMT3A and RUNX1 mutations (Supplementary Figure 9). This evidence concerns the gene RUNX1 and acute myeloid leukemia.